Key result
High thromboembolic risk is linked to just ~33% higher odds of post-discharge OAC initiation.
Why the study?
Atrial fibrillation is a common cause of stroke in older adults and is frequently first detected during hospitalization due to cardiac telemetry.
What is the rate of oral anticoagulant initiation in older adults newly diagnosed with atrial fibrillation during hospitalization?
Cohort (n=38,379)
Yes
What is the rate of oral anticoagulant initiation in older adults newly diagnosed with atrial fibrillation during hospitalization?
Oral anticoagulant initiation is uncommon among older adults newly diagnosed with atrial fibrillation during hospitalization, highlighting a potential gap in care.
Answers are grounded in this paper and cite their sources.
Minimal association of thromboembolic risk with oral anticoagulant initiation in hospitalized older adults with new AF; leaves open barriers to appropriate prescribing.
BACKGROUND: Atrial fibrillation is a common cause of stroke among older adults and is often first detected during hospitalization, given frequent use of cardiac telemetry. METHODS: In a 20% national sample of Medicare fee-for-service beneficiaries, we identified patients aged 65-or-older newly diagnosed with atrial fibrillation while hospitalized in 2016. Our primary outcome was an oral anticoagulant claim within 7-days of discharge. Multivariable logistic regression analyses assessed relationships between anticoagulation initiation and thromboembolic and bleeding risk scores while controlling for demographics, frailty, comorbidities, and hospitalization characteristics. Elevated HAS-BLED score was associated with a small decrease in probability of anticoagulant initiation (25.4% [CI, 24.4%-26.4%] for score <2 and 23.1% [CI, 22.5%-23.8%] for ≥3). Frailty was associated with decreased likelihood of oral anticoagulant initiation (24.7% [CI, 23.2%-26.2%] for non-frail and 18.1% [CI, 16.6%-19.6%] for moderately-severely frail). Anticoagulant initiation varied by primary reason for hospitalization, with predicted probability highest among patients with a primary diagnosis of atrial fibrillation (46.1% [CI, 45.0%-47.3%]) and lowest among those with non-cardiovascular conditions (13.8% [CI, 13.3%-14.3%]) and bleeds (3.6% [CI, 2.4%-4.8%]). CONCLUSIONS: Oral anticoagulant initiation is uncommon among older adults newly diagnosed with atrial fibrillation during hospitalization, even among patients hospitalized primarily for atrial fibrillation and patients with high thromboembolic risk. Clinicians should discuss risks and benefits of oral anticoagulants with all inpatients found to have atrial fibrillation.
No takes yet. Share an insight, caveat, or question.
Troy et al. (2023) conducted a cohort in Newly diagnosed atrial fibrillation during hospitalization (n=38,379). High thromboembolic risk (CHA2DS2-VASc score ≥ 4) vs. Low thromboembolic risk (CHA2DS2-VASc score < 2) was evaluated on Oral anticoagulant claim within 7 days of discharge (OR 1.33, 95% CI 1.16-1.51). High thromboembolic risk (CHA2DS2-VASc score ≥4) was associated with only a small increase in oral anticoagulant initiation compared to low risk (24.9% vs 20.5%, OR 1.33) among older adults newly diagnosed with atrial fibrillation during hospitalization.
Synapse has enriched 10 related papers. Consider them for comparative context: